Literature DB >> 1586362

Panic symptoms in asthma and panic disorder: a preliminary test of the dyspnea-fear theory.

R E Carr1, P M Lehrer, S M Hochron.   

Abstract

Ley's (Behaviour Research and Therapy, 27, 549-554, 1989) dyspnea-fear theory was tested on three groups of subjects: 10 with panic disorder, 24 with asthma, and 12 who were nonanxious and nonasthmatic, using measures of pulmonary function, muscle tension; and self-report measures of generalized anxiety, dyspnea, and psychopathology. Results are supportive of dyspnea-fear theory for asthmatics but not for individuals with panic disorder. Differences between groups on panic/fear measures were explained by a combination of general anxiety and dyspnea. Within-group regression analyses showed that only generalized anxiety symptoms contributed significantly to scores on the Asthma Symptom Checklist scale of panic/fear within the panic disorder group; while only dyspnea contributed to panic/fear among asthmatics. Additional results show that panic disorder subjects performed normally on pulmonary function tests but reported respiratory symptoms as severe as did asthmatics. Compared with normal subjects, both patient groups displayed lower correlations between self-rated symptoms of bronchoconstriction and objective pulmonary measures. Panic disorder subjects showed a negative relationship between pulmonary function and hyperventilation symptoms, suggesting a heightened sensitivity to, and discomfort with, sensations associated with normal pulmonary function. Asthmatics displayed a significant relationship between degree of airway obstruction and both trapezius surface EMG and ratings of hyperventilation symptoms.

Entities:  

Mesh:

Year:  1992        PMID: 1586362     DOI: 10.1016/0005-7967(92)90071-n

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  10 in total

1.  Health care use and quality of life among patients with asthma and panic disorder.

Authors:  Jonathan M Feldman; Paul M Lehrer; Soo Borson; Teal S Hallstrand; Mahmood I Siddique
Journal:  J Asthma       Date:  2005-04       Impact factor: 2.515

2.  Respiratory and cognitive mediators of treatment change in panic disorder: evidence for intervention specificity.

Authors:  Alicia E Meuret; David Rosenfield; Anke Seidel; Lavanya Bhaskara; Stefan G Hofmann
Journal:  J Consult Clin Psychol       Date:  2010-10

3.  Current perspectives on symptom perception in asthma: a biomedical and psychological review.

Authors:  S Rietveld; J F Brosschot
Journal:  Int J Behav Med       Date:  1999

4.  Childhood physical abuse and respiratory disease in the community: the role of mental health and cigarette smoking.

Authors:  Renee D Goodwin; Frederick S Wamboldt
Journal:  Nicotine Tob Res       Date:  2011-10-24       Impact factor: 4.244

Review 5.  Psychophysiological hypotheses regarding multiple chemical sensitivity syndrome.

Authors:  P M Lehrer
Journal:  Environ Health Perspect       Date:  1997-03       Impact factor: 9.031

6.  The role of panic-fear in comorbid asthma and panic disorder.

Authors:  Jonathan M Feldman; Mahmood I Siddique; Nigel S Thompson; Paul M Lehrer
Journal:  J Anxiety Disord       Date:  2008-07-01

Review 7.  Panic symptoms at the interface of body and mind.

Authors:  Eduardo A Colón
Journal:  Curr Psychiatry Rep       Date:  2006-06       Impact factor: 5.285

8.  Psychological treatment of comorbid asthma and panic disorder: a pilot study.

Authors:  Paul M Lehrer; Maria Katsamanis Karavidas; Shou-En Lu; Jonathan Feldman; Linda Kranitz; Smrithy Abraham; William Sanderson; Russ Reynolds
Journal:  J Anxiety Disord       Date:  2007-07-07

9.  A self-rating scale for patient-perceived side effects of inhaled corticosteroids.

Authors:  Juliet M Foster; Eric van Sonderen; Amanda J Lee; Robbert Sanderman; Antoon Dijkstra; Dirkje S Postma; Thys van der Molen
Journal:  Respir Res       Date:  2006-10-24

10.  Anxiety and panic fear in adults with asthma: prevalence in primary care.

Authors:  Cindy L Cooper; Glenys D Parry; Carol Saul; Alyn H Morice; Bruce J Hutchcroft; Julia Moore; Lisa Esmonde
Journal:  BMC Fam Pract       Date:  2007-10-26       Impact factor: 2.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.